| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |